Serveur d'exploration sur l'Indium - Analysis (France)

Index « Auteurs » - entrée « Loïc Campion »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Loïc Bertrand < Loïc Campion < Luc Brans  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000023 (2012) Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000094 (2006) Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131I-labeled bivalent hapten in a phase I optimization clinical trial.
000095 (2006) Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.
000139 (2002) Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.

List of associated KwdEn.i

Nombre de
documents
Descripteur
4Humans
3Radioimmunotherapy (methods)
3Thyroid Neoplasms (radiotherapy)
2Adult
2Aged
2Animals
2Antibodies, Bispecific (adverse effects)
2Carcinoembryonic Antigen (immunology)
2Male
2Mice
2Middle Aged
2Radioimmunotherapy (adverse effects)
2Survival Analysis
2Thyroid Neoplasms (pathology)
2Treatment Outcome
1Aged, 80 and over
1Antibodies, Bispecific
1Antibodies, Bispecific (administration & dosage)
1Antibodies, Bispecific (therapeutic use)
1Antibodies, Monoclonal (administration & dosage)
1Antibodies, Monoclonal (adverse effects)
1Antibodies, Monoclonal (therapeutic use)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Calcitonin (blood)
1Carcinoma, Medullary (pathology)
1Carcinoma, Medullary (therapy)
1Combined Modality Therapy
1Disease Progression
1Dose Fractionation
1Doxorubicin (therapeutic use)
1Female
1Haptens (administration & dosage)
1Haptens (adverse effects)
1Immunoglobulin G (therapeutic use)
1Indium (therapeutic use)
1Iodine Radioisotopes (administration & dosage)
1Iodine Radioisotopes (adverse effects)
1Iodine Radioisotopes (therapeutic use)
1Mice, Nude
1Neoplasm Metastasis
1Neoplasm Transplantation
1Paclitaxel (therapeutic use)
1Pentetic Acid
1Pentetic Acid (analogs & derivatives)
1Pentetic Acid (immunology)
1Pentetic Acid (therapeutic use)
1Prognosis
1Radiation Injuries (diagnosis)
1Radiation Injuries (etiology)
1Radiation-Sensitizing Agents (therapeutic use)
1Radioimmunotherapy
1Radiopharmaceuticals (administration & dosage)
1Radiopharmaceuticals (adverse effects)
1Radiotherapy Dosage
1Risk Assessment (methods)
1Thyroid Neoplasms (diagnosis)
1Thyroid Neoplasms (metabolism)
1Thyroid Neoplasms (mortality)
1Thyroid Neoplasms (therapy)
1Transplantation, Heterologous
1Tumor Cells, Cultured
1Tumor Markers, Biological (metabolism)
1Young Adult

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Loïc Campion" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Loïc Campion" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Loïc Campion
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024